文献速递肿瘤 PET/CT

高危儿童霍奇金淋巴瘤基线与中期PET预后评估:AHOD1331试验回顾分析

Evaluation of Baseline and Interim-Therapy PET Features for Prognostication in High-Risk Pediatric Hodgkin Lymphoma: A Retrospective Analysis of the AHOD1331 Trial.
PubMed 文献 · J Nucl Med · 2026-10-01

本研究基于儿童肿瘤协作组AHOD1331试验的558例高危儿童霍奇金淋巴瘤患者数据,回顾性评估常规与高级PET指标对无进展生存的预后价值。采用标准化建模流程(含特征选择与CoxNet惩罚回归)及按机构分层的嵌套交叉验证。结果显示,常规基线PET指标的CoxNet模型C-index最高(0.72±0.01),显著优于临床模型(0.65±0.01);加入影像组学或中期PET特征未提升性能;深度学习分割与医师勾画所提取特征的预后准确性相当(C-index均为0.72±0.01)。

要点

  • 常规基线PET定量指标较临床变量显著改善高危儿童HL的预后预测。
  • 加入影像组学特征或中期PET特征未进一步提升模型性能。
  • 深度学习自动分割所得特征与医师勾画特征预后准确性相当。

核心结论

  • 定量PET特征较临床变量提供显著预后改善,深度学习分割有望自动化特征提取并支持儿童HL风险分层。

研究设计与样本

  • 回顾性分析纳入儿童肿瘤协作组AHOD1331试验中150家机构的558例高危儿童霍奇金淋巴瘤患者,提取基线与中期PET的常规指标及影像组学特征。

主要发现

  • 常规基线PET指标的CoxNet模型C-index为0.72±0.01,显著优于临床模型0.65±0.01。
  • 加入影像组学特征或中期PET特征均未提升模型性能。
  • 基于深度学习分割的模型C-index为0.72±0.01,与基于医师勾画的模型相当。

关键数值与推荐

  • 模型性能以一致性指数(C-index)评估,采用按机构分层的嵌套交叉验证进行训练与外部测试。

临床怎么用

  • 在高危儿童霍奇金淋巴瘤中,可基于常规基线PET定量指标辅助预后分层,深度学习分割可简化特征提取流程。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

This study aimed to evaluate the prognostic value of conventional and advanced PET metrics for predicting progression-free survival in high-risk pediatric Hodgkin lymphoma (HL), using data from the Children's Oncology Group AHOD1331 trial. Methods: This retrospective analysis included 558 patients from 150 institutions. Conventional PET metrics and radiomics features were extracted from both baseline and interim-therapy PET images. Clinical variables, including demographic characteristics and common risk factors, were also considered. A standardized outcome-modeling pipeline was developed, comprising feature selection and penalized Cox regression with elastic net regularization (CoxNet). Models were trained and evaluated using nested cross-validation stratified by institution, ensuring consistent external testing. We investigated whether conventional PET metrics added prognostic value beyond clinical variables and whether radiomics or interim PET-derived features offered further benefit. Additionally, we compared the prognostic performance of features extracted from automated deep learning (DL) segmentations against those derived from physician annotations. Model performance was assessed using the concordance index (C-index). Results: Among all types of features, the CoxNet model using conventional baseline PET metrics achieved the highest performance (C-index, 0.72 ± 0.01), significantly outperforming the clinical model (C-index, 0.65 ± 0.01). Neither the inclusion of radiomics features nor interim PET-derived features improved performance. Models using DL-generated segmentations achieved comparable prognostic accuracy (C-index, 0.72 ± 0.01) to those using physician-based segmentations. Conclusion: Quantitative PET features provided significant prognostic improvements over clinical variables. Furthermore, DL-based segmentation offered a promising approach for automating feature extraction, supporting more effective risk stratification in pediatric HL.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Tie X, Lee C, Perlman SB, et al. Evaluation of Baseline and Interim-Therapy PET Features for Prognostication in High-Risk Pediatric Hodgkin Lymphoma: A Retrospective Analysis of the AHOD1331 Trial. J Nucl Med. 2026. PMID: 42315307. doi:10.2967/jnumed.125.270791

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。